Smith Hayes Advisers’s Sanofi SNY Stock Holding History

Smith Hayes Advisers’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,607	Closed	-$277K	–	323
2015 Q1	$277K	Hold	5,607	–	–	0.06%	262
2014 Q4	$256K	Sell	5,607 -278	-5%	-$13.5K	0.05%	262
2014 Q3	$332K	Sell	5,885 -611	-9%	-$32.8K	0.08%	227
2014 Q2	$345K	Buy	6,496 +211	+3%	+$11.2K	0.08%	217
2014 Q1	$329K	Buy	+6,285	New	+$318K	0.08%	214

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Smith Hayes Advisers's SNY Position: Q2 2015 in Review

Smith Hayes Advisers sold out of Sanofi (SNY) in Q2 2015, closing a stake of 5,607 shares — an estimated $277K sold.

Smith Hayes Advisers first reported a position in SNY in Q1 2014 and held it in 5 quarters. The position peaked at $345K in Q2 2014. 503 funds tracked by Wall St. Rank hold SNY as of Q2 2015.

Smith Hayes Advisers reported no remaining Sanofi position as of Q2 2015 after selling out during the quarter.
Smith Hayes Advisers sold 5,607 Sanofi shares in Q2 2015, an estimated $277K.
Smith Hayes Advisers first reported a position in Sanofi in Q1 2014 and held it in 5 quarters.
Smith Hayes Advisers's Sanofi position peaked at $345K in Q2 2014.
503 funds tracked by Wall St. Rank held Sanofi as of Q2 2015.

Based on Smith Hayes Advisers's 13F filing for Q2 2015, filed 13 Aug 2015.